Inhibition of rac1 reduces PDGF-induced reactive oxygen species and proliferation in vascular smooth muscle cells. by Kong, G. et al.
INTRODUCTION
Proliferation of vascular smooth muscle cell plays impor-
tant roles in atherosclerosis and restenosis after coronary
angioplasty (1, 2). However, the exact cellular mechanisms
responsible for smooth muscle cell proliferation are unknown.
For many years, reactive oxygen species (ROS), such as
superoxide anion (O2._) and hydrogen peroxide (H2O2), have
been thought of as toxic byproducts of aerobic living. But
recently, a variety of evidence suggests that ROS are involved
in the signal transduction in mammalian cells (3). In vascular
smooth muscle cells, ROS were shown to mediate platelet-
derived growth factor (PDGF)- or angiotensin II- induced
cell proliferation (4-6). The production of ROS in blood
vessel is enhanced in experimental models of hypercholes-
terolemia, hypertension, diabetes, and balloon injury to the
coronary arteries (7-10). These evidences suggest that ROS
could mediate the common mechanism of diseases charac-
terized by vascular smooth muscle cell proliferation.
The NADH/NADPH oxidase is the major source of ROS
induced by various growth factors in vascular smooth muscle
cell (11). In non-phagocytic cells, small GTP-binding pro-
tein rac1 controls the level of ROS by regulating the NADH/
NADPH oxidase complex (12-16). Recently, treatment with
antioxidants such as pyrrolidinedithiocarbamate (PDTC) or
N-acetylcysteine (NAC) and overexpression of catalase have
been shown to inhibit proliferation of vascular smooth mus-
cle cell by decreasing the level of intracellular ROS (17, 18).
These strategies decrease the preformed ROS.
In this study, we examined whether the inhibition of rac1
could inhibit the proliferation of rat aortic vascular smooth
muscle cell (RASMC) stimulated by PDGF via decreasing
the production of intracellular ROS. To inhibit NADH/
NADPH oxidase effectively, we used adenoviral-mediated
gene transfer of a dominant negative rac1 gene product
(N17rac1) as shown in the previous study (12).
MATERIALS AND METHODS
Cell Cultures
Primary culture of RASMC was obtained as explants from
the thoracic aorta of a 3-month-old Sprague-Dawley rat as
previously described (19). Cells were maintained in DMEM
(Gibco BRL, Grand Island, NY, U.S.A.) with 10% fetal calf
serum (Gibco BRL, Grand Island, NY, U.S.A.) in a humid-
ified atmosphere containing 5% CO2 at 37℃. For experi-
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Inhibition of rac1 Reduces PDGF-induced Reactive Oxygen Species
and Proliferation in Vascular Smooth Muscle Cells
In vascular smooth muscle cells, reactive oxygen species (ROS) were known to
mediate platelet-derived growth factor (PDGF)-induced cell proliferation and
NADH/NADPH oxidase is the major source of ROS. NADH/NADPH oxidase is
controlled by rac1 in non-phagocytic cells. In this study, we examined whether
the inhibition of rac1 by adenoviral-mediated gene transfer of a dominant nega-
tive rac1 gene product (Ad.N17rac1) could reduce the proliferation of rat aortic
vascular smooth muscle cells (RASMC) stimulated by PDGF via decreasing intra-
cellular ROS. RASMC were stimulated by PDGF (80 ng/mL) with or without N-
acetylcysteine 1 mM or infected with 100 mutiplicity of infection of Ad.N17rac1.
Intracellular ROS levels were measured at 12 hr using carboxyl-2′ ,7′ -dichlorodi-
hydrofluorescein diacetate confocal microscopy. At 72 hr, cellular proliferation
was evaluated by cell number counting and XTT assay. Compared with control,
ROS levels were increased by 2-folds by PDGF. NAC and Ad.N17rac1 inhibited
PDGF-induced increase of ROS by 77% and 65%, respectively. Cell number was
increased by PDGF by 1.6-folds compared with control. NAC and Ad.N17rac1
inhibited PDGF-induced cellular growth by 45% and 87%, respectively. XTT assay
also showed similar results. We concluded that inhibition of rac1 in RASMCs could
reduce intracellular ROS levels and cellular proliferation induced by PDGF.
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ment, RASMCs were pre-cultured on the same constitution
of media except 3% fetal bovine serum for 24 hr. All experi-
ments were performed on cells between passage 5 and 12
grown to about 80% confluence in 6-well or 96-well plates.
To stimulate proliferation of RASMC, PDGF (BB iso-
form) (Upstate Biotechnology, Waltham, MA, U.S.A.) 80
ng/mL was added to the media. The antioxidant, N-acetyl-
cysteine (Sigma, St. Louis, MO, U.S.A.) 1 mM was added
along with PDGF addition to see the antioxidant effect.
Adenoviruses
One hundred multiplicity of infection (MOI) of Ad.N17-
rac1 was infected in 3% fetal calf serum media 24 hr before
PDGF stimulation to allow sufficient gene expression in
RASMC. Adenovirus Ad.N17rac1 contains the epitope-
tagged dominant negative rac1 cDNA, which has a mutation
changing amino acid 17 of rac1 from serine to asparagine.
Construction of Ad.N17rac1 was done by homologous recom-
binant in 293 cells (13, 20). To assess the effects of adenovi-
ral infection alone, a control virus Ad.dl312, which is delet-
ed in the E1 region but lacks a recombinant transgene, was
used (21). Viruses were amplified, purified, and titrated as
previously described (22). All viruses were kindly presented
by Dr. Finkel T. at the Laboratory of Molecular Biology,
NHLBI.
Gene transfer efficiencies were assessed after infection with
Ad.GAL, an adenovirus, which encodes the Escherichia coli
LacZ gene product (22). Histochemical X-gal staining of
Ad. GAL-infected cells was performed as previously described
(22). Western blot analysis of rac1 expression used antibodies
directed at the myc-epitope tag (9E10; Santa Cruz Biotech.,
Heidelberg, Germany), which identified the N17rac1 gene
product (13). Twenty  g of protein was loaded in each lane
and bound immunoglobulins were detected by enhanced
chemiluminescence (Tropix, Bedford, MA, U.S.A.). Confir-
mation of equal protein loading was assessed using an anti-
body directed at  -tubulin (Ab-1; Calbiochem-Novabiochem
Corp., La Jolla, CA, U.S.A.).
Measuring Intracellular ROS
The level of intracellular ROS was measured at 12 hr after
PDGF stimulation with or without NAC and Ad.N17rac1
treatment. Intracellular generation of ROS was detected using
5-(and 6)-carboxyl-2′ ,7′ -dichlorodihydrofluorescein diacetate
(carboxyl-DCFH-DA) (Molecular Probes Inc., Eugene, OR,
U.S.A.) (23-26). Carboxyl-DCFH-DA fluoresces green when
oxidized by O2. or H2O2. The fluorescence was detected by
confocal laser scanning microscope using excitation and emis-
sion wavelengths of 488 and 525 nm, respectively, by incu-
bating cells for 5 min with 10  g/mL of carboxyl-DCFH-
DA as previously described (6). Levels of Carboxyl-DCFH-
DA fluorescence represent the values from at least 60 ran-
dom cells (mean±SD), based on an arbitrary scale of fluo-
rescence intensity (6).
Assessment of RASMC proliferation
The degrees of RASMC proliferation were evaluated at
72 hr after PDGF stimulation with or without NAC and
Ad.N17rac1 treatment. The RASMC proliferation was deter-
mined by two methods, cell number count using trypan blue
exclusion and XTT assay.  In cell number counts, only viable
cells by trypan dye are counted in hemocytometer as cells/
mL. ‘Cell Proliferation Kit II (XTT)’ (Boehringer Mannheim
Corp., Mannheim, Germany) was used for XTT assay. Fifty
L of XTT labeling mixture was added to each well of 96-
well plate and readings were done 24 hr later at 492 nm,
corrected against 690 nm.
Statistical analyses
Except when stated otherwise, all results are from tripli-
cate cultures (mean±SD) and represent one of at least three
similar experiments. Statistical significance was determined
by first performing an ANOVA between the experimental
groups (p<0.05), and then a two-tailed unpaired t-test to
compare N17rac1 with the other experimental groups.
RESULTS
We used primary cultures of RASMC as an in vitro model
for growth factor-induced ROS production and cell growth.
Fetal calf serum concentration of 3% was used because it was
the minimal concentration that showed linear growth pat-
tern. To select the growth factor for RASMC stimulation,
we tried angiotensin II, basic FGF and thrombin as well as
PDGF. PDGF was chosen because it showed the most promi-
nent ROS induction and cell growth. At 80 ng/mL, PDGF
showed maximal ROS induction and cell growth, and we
used this concentration for this experiment. NAC was used
as an antioxidant, because we observed that PDTC and cata-
lase induced significant cellular toxicity by trypan blue exclu-
sion in the preliminary experiments.
As demonstrated in Fig. 1, compared to the cells without
PDGF, the levels of intracellular ROS increased about 2-fold
after stimulation with PDGF 80 ng/mL for 12 hr. To see the
proliferative effect of PDGF, the cells were cultured with
PDGF 80 ng/mL for 72 hr and then cell number count and
XTT assay were performed. With PDGF, cell number in-
creased about 1.6-fold compared with control (Fig. 2A).
XTT assay showed a similar result with 1.8-fold increase in
absorbance (Fig. 2B).
Next, we assessed the effects of treating with the cell per-
meant chemical NAC. Consistent with previous studies that
demonstrated antiproliferative effects of ROS scavengers by714 G. Kong, S. Lee, K.-S. Kim
decreasing intracelluar ROS levels (10, 17), treatment with
NAC 1 mM inhibited the increase of intracelluar ROS lev-
els (Fig. 1) and the cell proliferation (Fig. 2) induced by
PDGF. We have used 1 mM of NAC, because at that con-
centration, NAC showed the maximal inhibitory effects to
induce ROS and promote cell growth.
Consistent with previous results in vascular smooth mus-
cle cells (27, 28), adenoviral infection at concentration of
100 MOI led to a successful gene transfer in >95% of
infected cells (Fig. 3A). Similarly, Western blot analysis of
Ad.N17rac1 infected cells demonstrated that the epitope-
tagged form of dominant negative rac1 gene product was
expressed at a high level (Fig. 3B).
After confirmation of the high efficiency of adenoviral-
mediated gene transfer, we examined the effect of inhibition
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Fig. 1. Effects of PDGF and NAC on the levels of reactive oxygen species in rat aortic smooth muscle cells. (A) Representative images
obtained by carboxyl-DCFH-DA confocal laser microscopy. Left upper panel: control cells. PDGF: cells incubated with PDGF 80 ng/mL
for 12 hr. PDGF+NAC: cells co-incubated with PDGF 80 ng/mL and NAC 1 mM for 12 hr. (B) Levels of carboxyl-DCFH-DA fluorescence
measured by confocal laser microscopy. Cells were incubated with PDGF 80 ng/mL (PDGF) or NAC 1 mM (NAC) for 12 hr. 
p<0.05, *: PDGF (-) NAC (-) vs. PDGF (+) NAC (-), **: PDGF (+) NAC (-) vs. PDGF (+) NAC (+).
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Fig. 2. Effects of PDGF and NAC on the proliferations of rat aortic smooth muscle cells. (A) Effects of PDGF and NAC on cell numbers. (B)
Effects of PDGF and NAC on relative absorbance at 492 nm on XTT assay. Cells were incubated with PDGF 80 ng/mL (PDGF) or NAC 1
mM (NAC) for 72 hr. p<0.05, *: PDGF (-) NAC (-) vs. PDGF (+) NAC (-), **: PDGF (+) NAC (-) vs. PDGF (+) NAC (+).
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of rac1. To determine whether the inhibition of rac1 could
suppress the increase of intracellular ROS levels and cellular
proliferation by PDGF stimulation, we used adenoviral-medi-
ated gene transfer of a dominant negative rac1 (Ad.N17rac1).
Previous studies have implicated that rac1 plays an impor-
tant role in ligand-stimulated ROS generation in non-phago-
cytic cells (13-15, 29, 30). Examination of intracellular ROS
levels revealed that in uninfected cells, the stimulation with
PDGF produced a significant increase in carboxyl-DCFH-
DA fluorescence (Fig. 4). Similar increase in the fluorescence
was seen in the cells infected with an E1-deleted adenovirus,
which lacked a recombinant transgene (Ad.dl312; Fig. 4).
By contrast, the cells infected with Ad.N17rac1 showed a
significant attenuation in the level of ROS, as assessed by
carboxyl-DCFH-DA fluorescence, after stimulation with
PDGF (Fig. 4).
Next, we assessed the effects of N17rac1 expression on
cell proliferation after stimulation with PDGF. In the cells
treated with PDGF only or PDGF plus Ad.dl312, the num-
ber of cells was increased significantly, about 2-folds, com-
pared with control (Fig. 5A). By contrast, in the cells infect-
ed with Ad.N17rac1, PDGF induced a significant attenua-
tion in cell growth by approximately a half of the cell num-
ber (Fig. 5A). Similarly, according to the results by the XTT
assay, the cells infected with Ad.N17rac1 showed signifi-
cant decreases of absorbance compared with the cells treated
with PDGF only or PDGF plus Ad.dl312 (Fig. 5B).
DISCUSSION
We found that in RASMCs the inhibition of rac1 by infec-
Fig. 4. Effects of Ad.N17rac1 infection on the levels of reactive oxygen species in rat aortic smooth muscle cells. (A) Representative
images obtained by carboxyl-DCFH-DA confocal laser microscopy. Control: uninfected control cells. PDGF cells incubated with PDGF
80 ng/mL. PDGF+Ad.dl312: cells incubated with PDGF 80 ng/mL and infected with 100 mutiplicity of infection (MOI) of Ad.dl312.
PDGF+ Ad.N17rac1: cells incubated with PDGF 80 ng/mL and infected with 100 MOI of Ad.N17rac1. Confocal images were obtained
12 hr after incubation with PDGF and viral infections were performed 24 hr before the start of incubation with PDGF. (B) Levels of car-
boxyl-DCFH-DA fluorescence measured by confocal laser microscopy. Cells were incubated with PDGF 80 ng/mL (PDGF) or infected
with 100 MOI of Ad.dl312 or Ad.N17rac1 as described in (A).
p<0.05, from left to right, *: 1st vs. 2nd, **: 1st vs. 3rd , ***: 2nd vs. 4th, ****: 3rd vs. 4th bar. 
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Fig. 3. Assessment of adenoviral-mediated gene transfer. (A)
Histochemical X-gal staining 24 hr after infection with 100 muti-
plicity of infection of Ad.GAL, which encodes the Escherichia
coli LacZ gene product, showed over 95% gene transfer effi-
ciency. (B) Western blots of protein lysates (20  g) obtained
from uninfected RASMC (left lane), RASMC infected with
Ad.dl312 (middle lane), and Ad.N17rac1 (right lane). Western
blotting analysis was proved with  -tubulin to confirm equal
loading and an antibody (21 kDa) recognizing the myc epitope
tag of N17rac1 construct.
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Fig. 5. Effects of Ad.N17rac1 infection on the proliferations of rat aortic smooth muscle cells. (A) Effects of Ad.N17rac1 infection on cell
numbers. (B) Effects of Ad.N17rac1 infection on relative absorbance at 492 nm on XTT assay. Cells were incubated with PDGF 80
ng/mL (PDGF) or infected with 100 mutipicity of infection of Ad.dl312 or Ad.N17rac1. Cell number counting and XTT assay were per-
formed 72 hr after incubation with PDGF and viral infections were performed 24 hr before the start of incubation with PDGF. 
p<0.05, from left to right, *: 1st vs. 2nd, **: 1st vs. 3rd , ***: 2nd vs. 4th, ****: 3rd vs. 4th bar. 
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tion with AdN17rac1, an adenovirus containing gene encod-
ing a dominant negative rac1 gene product, resulted in a
high expression of N17rac1 in the cells, reduction in the
levels of intracellular ROS, and suppression of DNA syn-
thesis and cellular proliferation induced by PDGF stimula-
tion.
Ligand-stimulated ROS production plays an important
role in signal transduction in various cells (3, 31-33) and
especially, growth factors, such as PDGF, epidermal growth
factor, and angiotensin II trigger the rapid production of ROS.
Also, ROS can stimulate proliferation of vascular smooth
muscle cell (5, 34). Furthermore, in RASMC, PDGF stimu-
lated H2O2 production and DNA synthesis, and both of
these responses are blocked by antioxidant treatment (6).
These reports and our study suggest that endogenously pro-
duced ROS have an important role in regulating vascular
smooth muscle cell growth.
In phagocytic cells, a variety of stimuli cause burst of super-
oxide anion through NADPH oxidase (35). The small GTPase
rac2 is one of the essential components of NADPH oxidase
complex and controls the activity of the enzyme complex (29,
30). Recent evidences suggest that in non-phagocytic cells,
similar enzyme complex, NADPH/NADH oxidase is con-
trolled by rac1 (13, 14, 16). Furthermore, NADPH/NADH
oxidase is the major source of ROS induced by various growth
factors in vascular smooth muscle cell (11). In this experiment,
we inhibited NADPH/NADH oxidase in RASMC using
rac1 inhibition by adenoviral-mediated gene transfer of a
dominant negative rac1 (N17rac1). And we demonstrated
that this resulted in a reduction of intracellular ROS levels
and suppression of DNA synthesis and cellular proliferation.
This is the first report to show that the over-expression of
N17rac1 could inhibit cellular proliferation induced by
PDGF.
Some reports have shown that ROS could induce apopto-
sis rather than proliferation in vascular smooth muscle cells
(34, 36, 37). These findings are most likely due to the dif-
ferences in the amount of ROS applied, but the exact mech-
anisms remain to be determined.
Usually to see the effects of growth factors, experiments
are performed by serum deprivation or at the minimal serum
concentration. In this experiment, we have used fetal calf
serum of 3%, which was to observe cell growth on a linear
growth phase. We thought this was more physiological than
a serum-deprived condition. Due to relatively high serum
concentration in controls, PDGF-induced increases in intra-
cellular ROS levels, XTT absorbances and cellular prolifera-
tions were not so prominent.
Carboxyl-DCFH-DA confocal microscopy to measure the
intracellular ROS levels can not discriminate between indi-
vidual ROS, that is, superoxide anion (O2._), hydrogen per-
oxide (H2O2), hydroxyl radical (.OH), and nitric oxide (NO).
So, we could not observe the effects of individual ROS.
Nonetheless, our data suggest that under certain condi-
tions, inhibition of rac1 in RASMC can reduce intracellular
ROS levels and cellular proliferation induced by PDGF. The
inhibition of rac1 protein function may be useful in variety
of clinical settings, such as restenosis after coronary inter-vention, in which the proliferation of vascular smooth mus-
cle cells plays an important role in pathogenesis.
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